Chronic pain clinical trials in Markham, Ontario
Part of chronic pain trials in Ontario.
2
Trials
0
Recruiting or not yet
2
Trial sites
Trials with a site in Markham
2 trials, recruiting first
| Phase | ||||
|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention NCT03238781 | Completed | Phase 2 | Amgen | 2017-09-06 |
| An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain NCT00487435 | Completed | Phase 3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-06 |
Facilities listed in the registry
- Research Site (1 trial site)
Facility names are as entered by study registrants. This is not a clinic directory.
Map
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.